- Home
- App-Analyse
- Transplant (HCT) Guidelines
- Transplant (HCT) Guidelines Vs. CARTOX
Transplant (HCT) Guidelines im Vergleich zu CARTOX Nutzung und Statistiken
The Transplant Guidelines App provides recommended referral consultation timing guidelines and post-transplant screening, immunization and GVHD screening guidelines for hematologists/oncologists.
• Quickly access optimal referral consultation timing for 15+ diseases, including AML, ALL, MDS, CML, NHL, Hodgkin lymphoma, multiple myeloma and sickle cell disease
• Access the latest HCT research and outcomes data
• Create customized lists of recommended post-transplant tests/procedures for 6-month, 12-month and annual appointments
• Check potential signs/symptoms of chronic GVHD by area of the body and view photo gallery of manifestations
• View vaccination schedules for autologous and allogeneic HCT recipients
• See the latest conference research
• Access media including podcasts, videos, and webinars
• HLA typing via HLA Today
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
Cellular therapies can be associated with unique, acute toxicities which can be severe or even fatal if not identified early and treated appropriately.
Cytokine Release Syndrome (CRS), the most commonly observed toxicity can range in severity from low-grade constitutional symptoms to high-grade syndrome associated with life-threatening multi-organ disfunction. Neurotoxicity, originally termed CRES (CAR-Related Encephalopathy Syndrome) and now updated to ICANS (Immune effector Cell-Associated Neurotoxicity Syndrome) is the second most-common adverse even and can occur concurrently with CRS. A multi-disciplinary working group was formed to address safety issues for patients receiving cellular therapy which led to the development of new grading methods and treatment algorithms that have been incorporated into the CARTOX mobile app.
The CARTOX mobile app assists with grading toxicities, managing toxicities and assists with recommendations regarding appropriate antimicrobial prophylaxis for patients who have received immune effector cell therapy. Users are more easily able to determine if the patient is having cytokine release syndrome or neurotoxicity and to grade those toxicities.
Intended audience: Clinicians (physicians, nurse practitioners, physician assistants, pharmacists, nurses) who treat/care for patients receiving immune effector cells.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
Transplant (HCT) Guidelinesvs. CARTOX Ranking-Vergleich
Vergleichen Sie Transplant (HCT) Guidelines den Ranking-Trend der letzten 28 Tage mit CARTOX
Rang
Keine Daten verfügbar
Transplant (HCT) Guidelines im Vergleich zu CARTOX Ranking im Ländervergleich
Vergleichen Sie Transplant (HCT) Guidelines den Ranking-Trend der letzten 28 Tage mit CARTOX
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
Transplant (HCT) Guidelines VS.
CARTOX
Dezember 31, 2024